Regeneron Pharmaceuticals Inc. buy piccolo90
Summary
This prediction ended on 02.08.18 with a price of €345.05. The prediction had a final performance of 24.60%. piccolo90 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Regeneron Pharmaceuticals Inc. | 4.683% | 4.683% | 36.117% | 116.361% |
iShares Core DAX® | -2.023% | -3.140% | 10.499% | 13.078% |
iShares Nasdaq 100 | 4.625% | 8.753% | 34.939% | 57.906% |
iShares Nikkei 225® | -2.088% | -0.980% | 3.292% | 2.524% |
iShares S&P 500 | 2.398% | 4.677% | 27.998% | 49.604% |
Comments by piccolo90 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 13.05.2018 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 382.27$ zu.
Stopped prediction by piccolo90 for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
02.10.18
10.07.19
10.07.19
Regeneron Pharmaceuticals Inc.
21.12.17
06.03.18
06.03.18
Regeneron Pharmaceuticals Inc.
04.04.17
04.10.17
04.10.17
Regeneron Pharmaceuticals Inc.
03.05.16
03.11.16
03.11.16
Regeneron Pharmaceuticals Inc.
28.07.15
04.08.15
04.08.15